sodium hyaluronate gel
Commercial- Indications
- Ophthalmology, Orthopedics, Surgery
Company intelligence / Profile preview
Shanghai Qisheng Biological Preparation Co., Ltd.
Shanghai, Shanghai, Chinashqisheng.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company has conducted at least one Phase 4 clinical trial (NCT02323451) comparing medical chitosan with sodium hyaluronate injection for knee osteoarthritis. Their chitosan nerve conduit has shown efficacy in repairing rat peripheral nerve defects with no significant difference compared to control groups in terms of histomorphology of regenerated nerve fibers and gastrocnemius muscle.[3]
- Therapeutic areas
- OtherDermatologyRheumatologyOphthalmologyNeurologyWomen's Health
- Modalities
- BiomaterialsBiodegradable materials
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Shanghai Qisheng Biological Preparation Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Qisheng Biological Preparation Co., Ltd..